Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients? (Q34453336)

2 August 2017

title

Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients? (English)

1 reference

2 August 2017

J Vignau

1

1 reference

2 August 2017

A Duhamel

2

1 reference

2 August 2017

J Catteau

3

1 reference

2 August 2017

G Legal

4

1 reference

2 August 2017

A H Pho

5

1 reference

2 August 2017

I Grailles

6

1 reference

2 August 2017

J Beauvillain

7

1 reference

2 August 2017

P Petit

8

1 reference

2 August 2017

P Beauvillain

9

1 reference

2 August 2017

P J Parquet

10

1 reference

2 August 2017

language of work or name

1 reference

1 October 2001

1 reference

Journal of Substance Abuse Treatment

2 August 2017

published in

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

135-144

1 reference

Psychiatric disorders of opioid addicts entering treatment: preliminary data

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Deaths attributable to methadone vs buprenorphine in France

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

The impact on retention of expansion of an Australian public methadone program.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

High dose buprenorphine for postoperative analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Creating a new drug service in Edinburgh

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Drug users' views on general practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Buprenorphine and naloxone for heroin dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Psychiatric comorbidity in methadone maintained patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Supervised administration of methadone by pharmacists

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Office-based methadone prescribing: acceptance by inner-city practitioners in New York.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Community based heroin addicts who turn to experimental treatment rather than conventional care.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Prevalence and improvement in psychopathology in opioid dependent patients participating in methadone maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Injecting misuse of buprenorphine among French drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Opioid addiction treatment modalities and some guidelines to their optimal use.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

A 12-Year Follow-Up of a Methadone Medical Maintenance Program

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Community pharmacists are increasingly supervising treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Differences between general practitioner- and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2801%2900189-1

7 January 2021

10.1016/S0740-5472(01)00189-1

Identifiers

DOI

1 reference

2 August 2017

1 reference